Medicare Enrolled
Dr. Dennis Cesar, M.D.
Urology Physician · Merced, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cesar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cesar?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cesar
Dr. Dennis Cesar is an urology physician in Merced, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Cesar performed 10,101 Medicare services across 3,576 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cesar received a total of $6,269 from 45 pharmaceutical and/or device companies across 295 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cesar is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 11% volume in CA
$6,269 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,101
Medicare services
Top 11% in CA for urology physician
3,576
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~561 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, degarelix, 1 mg | 3,360 | $3 | $8 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,951 | $63 | $183 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
1,155 | $8 | $23 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 348 | $134 | $375 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
317 | $105 | $427 |
| Lower leg neurostimulator electrode insertion A procedure to place an electrode in the lower leg for neurostimulation therapy. |
258 | $90 | $246 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
223 | $46 | $127 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
187 | $109 | $336 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
175 | $10 | $29 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
129 | $28 | $71 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
120 | $184 | $502 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
119 | $26 | $131 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
118 | $6 | $30 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
117 | $293 | $768 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
94 | $128 | $363 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
66 | $259 | $679 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
66 | $18 | $48 |
| Injection, garamycin, gentamicin, up to 80 mg | 50 | $2 | $6 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
45 | $102 | $257 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
37 | $36 | $101 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
37 | $63 | $157 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
33 | $551 | $1,429 |
| Bladder emptying assessment A timed evaluation to measure how effectively the bladder empties urine. |
25 | $6 | $27 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
25 | $52 | $183 |
| Simple measurement of urine flow pressure in bladder A test that measures the pressure of urine flow within the bladder. This procedure assesses bladder function by recording pressure changes during urination. |
17 | $96 | $477 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow within the bladder to evaluate how well the bladder and urethra are functioning. |
15 | $195 | $632 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
14 | $518 | $1,817 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,269
Total received (2018-2024)
Avg $896/year across 7 years
Top 28% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
295
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,826 (92.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$442 (7.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,877
2023
$1,209
2022
$860
2021
$1,080
2020
$284
2019
$477
2018
$481
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ACCORD HEALTHCARE, INC.
$237
Astellas Pharma US Inc
$225
Sumitomo Pharma America, Inc.
$196
Janssen Biotech, Inc.
$192
Antares Pharma, Inc.
$176
UROGEN PHARMA, INC.
$147
ABBVIE INC.
$103
Myriad Genetic Laboratories, Inc.
$101
Dendreon Pharmaceuticals LLC
$91
Telix Pharmaceuticals
$81
PFIZER INC.
$52
Merck Sharp & Dohme LLC
$45
Novartis Pharmaceuticals Corporation
$34
Olympus America Inc.
$24
Boston Scientific Corporation
$22
KARL STORZ Endoscopy-America
$20
COLOPLAST CORP
$19
AstraZeneca Pharmaceuticals LP
$18
IMMUNITYBIO, INC.
$17
Axonics, Inc.
$17
Tolmar, Inc.
$16
ConvaTec Inc.
$15
Laborie Medical Technologies Corp.
$14
Ferring Pharmaceuticals Inc.
$14
Top 3 companies account for 35.1% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$797
Dendreon Pharmaceuticals LLC
$677
Coloplast Corp
$388
Myriad Genetic Laboratories, Inc.
$385
UROVANT SCIENCES INC
$350
Janssen Biotech, Inc.
$295
Sumitomo Pharma America, Inc.
$287
ACCORD HEALTHCARE, INC.
$237
Antares Pharma, Inc.
$228
Boston Scientific Corporation
$219
UROGEN PHARMA, INC.
$201
Dornier MedTech America, Inc
$184
COLOPLAST CORP
$163
ABBVIE INC.
$162
Myovant Sciences Inc.
$157
Telix Pharmaceuticals
$153
TOLMAR Pharmaceuticals, Inc.
$147
AbbVie Inc.
$139
Ferring Pharmaceuticals Inc.
$111
BOSTON SCIENTIFIC CORPORATION
$90
Teleflex LLC
$84
PFIZER INC.
$79
UroGen Pharma, Inc.
$78
Tolmar, Inc.
$66
Avadel Specialty Pharmaceuticals, LLC
$60
Bayer HealthCare Pharmaceuticals Inc.
$59
Merck Sharp & Dohme LLC
$45
Axonics, Inc.
$42
AbbVie, Inc.
$42
Olympus America Inc.
$36
AstraZeneca Pharmaceuticals LP
$34
Novartis Pharmaceuticals Corporation
$34
Allergan, Inc.
$27
Supernus Pharmaceuticals, Inc.
$26
NeoTract Inc.
$25
KARL STORZ Endoscopy-America
$20
180 Medical, Inc.
$19
IMMUNITYBIO, INC.
$17
Augmenix, Inc.
$17
Retrophin, Inc.
$17
ConvaTec Inc.
$15
Endo Pharmaceuticals Inc.
$15
DENTSPLY IH AB
$15
Laborie Medical Technologies Corp.
$14
Axonics Modulation Technologies, Inc.
$12
Top 3 companies account for 29.7% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AMS 700 · ANKTIVA · Androgel · Axonics · Axonics r-SNM System · BOTOX · CAMCEVI · CONTINENCE CARE · Dornier MedTech · ELIGARD · ERLEADA · Eclipse · FIRMAGON · GEMTESA · GENERAL BPH · GENERAL - BPH · GENERAL ERECTILE DYSFUNCTION · GENTLECATH · GENTLECATH GLIDE · ILLUCCIX · Isiris A · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · LoFric · Lupron Depot · MYRBETRIQ · MYRISK · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · PLUVICTO · PROLARIS · PROVENGE · Prolaris · Rezum Generator · SpaceOAR · SpeediCath · TITAN · Titan · UROLIFT · UroLift · UroLift System · VIRTUE · Veozah · XIAFLEX · XTANDI · XYOSTED · Xtandi · iTIND System · n.a.
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
4
Per 100K population
1.4
County median income
$65,044
Nearest hospital
MERCY MEDICAL CENTER
9.2 mi
9.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cesar is a clinical cardiology specialist, with above-average Medicare volume (top 11% in CA), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cesar experienced with injection, degarelix, 1 mg?
Based on Medicare claims data, Dr. Cesar performed 3,360 injection, degarelix, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cesar receive payments from pharmaceutical companies?
Yes. Dr. Cesar received a total of $6,269 from 45 companies across 295 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cesar's costs compare to other urology physicians in Merced?
Dr. Cesar's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cesar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Merced
Browse urology physicians in Merced ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology